Cargando…
The rho kinase inhibitor Y-27632 improves motor performance in male SOD1(G93A) mice
Disease progression in amyotrophic lateral sclerosis (ALS) is characterized by degeneration of motoneurons and their axons which results in a progressive muscle weakness and ultimately death from respiratory failure. The only approved drug, riluzole, lacks clinical efficacy so that more potent treat...
Autores principales: | Günther, René, Saal, Kim-Ann, Suhr, Martin, Scheer, David, Koch, Jan Christoph, Bähr, Mathias, Lingor, Paul, Tönges, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187656/ https://www.ncbi.nlm.nih.gov/pubmed/25339858 http://dx.doi.org/10.3389/fnins.2014.00304 |
Ejemplares similares
-
Rho Kinase Inhibition with Fasudil in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis—Symptomatic Treatment Potential after Disease Onset
por: Günther, René, et al.
Publicado: (2017) -
ROCKing Regeneration: Rho Kinase Inhibition as Molecular Target for Neurorestoration
por: Tönges, Lars, et al.
Publicado: (2011) -
Viral vector-mediated downregulation of RhoA increases survival and axonal regeneration of retinal ganglion cells
por: Koch, Jan Christoph, et al.
Publicado: (2014) -
Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson’s disease
por: Tönges, Lars, et al.
Publicado: (2012) -
Axonal degeneration as a therapeutic target in the CNS
por: Lingor, Paul, et al.
Publicado: (2012)